# Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

> **NCT00121147** · NA · COMPLETED · sponsor: **Hermann Eye Center** · enrollment: 200 (—)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension
- Pseudoexfoliation Syndrome

## Interventions

- **DRUG:** Travatan
- **DRUG:** Azopt
- **DRUG:** Alphagan P

## Key facts

- **NCT ID:** NCT00121147
- **Lead sponsor:** Hermann Eye Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121147, "Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00121147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*